&Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.3M | Buy |
273,590
+171,989
| +169% | +$19.1M | 0.23% | 97 |
|
|
2025
Q1 | $11.4M | Buy |
101,601
+3,272
| +3% | +$366K | 0.12% | 163 |
|
|
2024
Q4 | $8.99M | Buy |
98,329
+37,315
| +61% | +$3.41M | 0.11% | 188 |
|
|
2024
Q3 | $5.12M | Buy |
61,014
+35,279
| +137% | +$2.96M | 0.1% | 201 |
|
|
2024
Q2 | $1.76M | Buy |
25,735
+21,511
| +509% | +$1.47M | 0.08% | 232 |
|
|
2024
Q1 | $309K | Buy |
+4,224
| New | +$309K | 0.04% | 358 |
|
|
2020
Q2 | – | Sell |
-2,700
| Closed | -$202K | – | 143 |
|
|
2020
Q1 | $202K | Buy |
+2,700
| New | +$202K | 0.31% | 100 |
|